Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Amgen, Janssen team up in trial collaboration for myeloma

Executive Summary

Janssen Biotech Inc. and Amgen Inc.'s Onyx Pharmaceuticals Inc. entered into a trial collaboration agreement to evaluate the efficacy and safety of Janssen's Darzalex (daratumumab) in combination with Onyx's Kyprolis carfilzomib and dexamethasone as a treatment for cancer.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Alliance
    • Trial Collaborations

Related Companies

UsernamePublicRestriction

Register